Condition
SLE clinical trials and research
As of November 12, 2026, Find a Trial lists 10 SLE clinical trials that are recruiting, at sites in 13 countries (most in United States (4), China (3), Australia (1)). 1 was first registered in the last 30 days. By phase: Early Phase 1 (3), Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 1New in 30 days
- 13Countries
Newest SLE clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting SLE Flares with Patient Reports and Machine Learning | — | Sohag, Nasr City | Recruiting | Oct 22, 2026 |
| Anti-CD19/BCMA universal CAR-T (RD06-05) for autoimmune diseases | Early Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Oct 2, 2025 |
| Pregnancies before a lupus diagnosis | — | Aïn Taya, Algiers Province and 1 other locations | Recruiting | Aug 29, 2025 |
| ONT01 for Lupus Nephritis and Systemic Lupus Erythematosus | Early Phase 1 | New York, New York | Recruiting | Aug 6, 2025 |
| CART19 treatment for lupus in young patients | Phase 1/2 | Philadelphia, Pennsylvania | Recruiting | Feb 21, 2025 |
| Targeted CAR-T therapy for autoimmune diseases | Early Phase 1 | Lianyungang, Jiangus | Recruiting | Jan 15, 2025 |
| Cell therapy using UC-MSCs for patients with lupus | Phase 1 | Charleston, South Carolina | Recruiting | Dec 17, 2024 |
| Using CLN-978 to treat patients with systemic lupus erythematosus | Phase 1 | Avondale, Arizona and 23 other locations | Recruiting | Sep 25, 2024 |
| Evaluating APG-2575 for mild-to-moderate lupus | Phase 1/2 | Shanghai, Shanghai Municipality | Recruiting | Dec 27, 2023 |
| Registry of Argentinian patients with lupus | — | La Plata, Buenos Aires | Recruiting | Jul 22, 2022 |
All recruiting trials (10)
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Anti-CD19/BCMA universal CAR-T (RD06-05) for autoimmune diseases
This early-phase test gives a universal CAR-T therapy (RD06-05) that targets CD19 and BCMA to adults with autoimmune diseases such as SLE/lupus nephritis, ANCA-associated vasculitis, and anti-GBM disease.
-
Pregnancies before a lupus diagnosis
See if pregnancies that happened before women were diagnosed with lupus showed early lupus signs and how those pregnancies affected mothers and babies.
-
ONT01 for Lupus Nephritis and Systemic Lupus Erythematosus
We will test whether ONT01 is safe and helps adults with lupus nephritis or active SLE when added to standard medicines like mycophenolate.
-
CART19 treatment for lupus in young patients
This study is testing a new treatment called CART19 to see if it can help young people aged 12-29 with tough-to-treat lupus feel better and improve their health.
-
Targeted CAR-T therapy for autoimmune diseases
This study is testing a new CAR-T cell therapy to see if it can help people with autoimmune diseases like lupus, scleroderma, and multiple sclerosis feel better.
-
Cell therapy using UC-MSCs for patients with lupus
This study is testing if a new treatment using stem cells from umbilical cords can help adults with lupus feel better and improve their kidney health.
-
Using CLN-978 to treat patients with systemic lupus erythematosus
This study is testing a new treatment called CLN-978 to see if it can help people with moderate to severe lupus who haven't responded well to other treatments.
-
Evaluating APG-2575 for mild-to-moderate lupus
This study is testing a new drug called APG-2575 to see if it is safe and effective for people with mild-to-moderate lupus.
-
Registry of Argentinian patients with lupus
This study is gathering information from Argentinian patients with lupus over five years to better understand their experiences, treatments, and health outcomes.
Related topics
Quick answers
How many SLE clinical trials are recruiting right now?
10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in United States (4 trials), China (3 trials), Australia (1 trial), Bulgaria (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 3, Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.